DNA profiles to be deleted from police database
By BBC,
BBC News [United Kingdom]
| 02. 11. 2011
Hundreds of thousands of DNA profiles on the national database will be deleted, the government has announced.
Under the proposals, police will no longer be able to retain the DNA profile of most people who are arrested but not subsequently convicted.
At present, the National DNA Database retains the profiles of anyone arrested, irrespective of the outcome.
The changes will bring the law in England, Wales and Northern Ireland into line with Scotland.
Under the measures, set out in the coalition's Protection of Freedoms Bill, any adult convicted of a crime, or child convicted of a serious crime, will still have their DNA profile stored indefinitely in the national database.
But following a critical European Court of Human Rights ruling, there will be wide-ranging changes to when profiles can otherwise be kept.
If an adult is arrested for a serious offence, but not convicted, the profile can be kept for three years with a possible further two-year extension with court approval.
But most of those arrested for less serious offences will see their profile deleted if they are not subsequently...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...